New drug for Duchenne muscular dystrophy clears phase 1 clinical trial testing in boys

Friday, February 22, 2019 - 09:00 in Health & Medicine

Patients with Duchenne muscular dystrophy (DMD) have few treatment options. Medications currently available or in development either target only a subset of DMD patients with a particular genetic mutation or cause significant side effects.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net